Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 35 (1) , 35-41
- https://doi.org/10.1016/s0169-5002(01)00287-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Study of prognostic predictors for non-small cell lung cancerLung Cancer, 1999
- The p53 pathwayThe Journal of Pathology, 1999
- Clinical implications of molecular abnormalities in lung cancerCancer Treatment Reviews, 1998
- Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 geneBritish Journal of Cancer, 1998
- Non-small cell lung cancer: clinical value of new biological predictorsLung Cancer, 1997
- Prognostic value of p53 in non-small cell lung cancer: Relationship with proliferating cell nuclear antigen and cigarette smokingHuman Pathology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survivalAnnals of Oncology, 1995
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Cyclin/PCNA is the auxiliary protein of DNA polymerase-δNature, 1987